Evidence map›Paper›PMID 23666239›Full record

SynthesisNature genetics2013

Meta-analysis identifies four new loci associated with testicular germ cell tumor.

Charles C Chung, Peter A Kanetsky, Zhaoming Wang, Michelle A T Hildebrandt, Roelof Koster, Rolf I Skotheim, Christian P Kratz, Clare Turnbull, Victoria K Cortessis, Anne C Bakken and 20 more

Registry-linked trialAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00034424 (Multidisciplinary Etiologic Study of Familial Testicular Cancer), which is not on this map. Cited by 100 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 7 pooled it
21.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00034424 completednot on this map

Multidisciplinary Etiologic Study of Familial Testicular Cancer

TypeobservationalSponsorNational Cancer Institute (NCI)Ran2003Enrolled749ConditionsTesticular Cancer
3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 7 syntheses or guidelines pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Evolutionary Origins of Metabolic Reprogramming in Cancer.International journal of molecular sciences · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 14 institutions in 3 countries.

Charles C ChungDivision of Cancer Epidemiology and Genetics, National Cancer Institute NCI, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
Peter A Kanetsky
Zhaoming Wang
Michelle A T Hildebrandt
Roelof Koster
Rolf I Skotheim
Christian P Kratz
Clare Turnbull
Victoria K Cortessis
Anne C Bakken
D Timothy Bishop
Michael B Cook
R Loren Erickson
Sophie D Fosså
Kevin B Jacobs
Larissa A Korde
Sigrid M Kraggerud
Ragnhild A Lothe
Jennifer T Loud
Nazneen Rahman
Eila C Skinner
Duncan C Thomas
Xifeng Wu
Meredith Yeager
Fredrick R Schumacher
Mark H Greene
Stephen M Schwartz
Katherine A McGlynn
Stephen J Chanock
Katherine L Nathanson
National Institutes of Health · USUniversity of Oslo · NOUniversity of Pennsylvania · USUniversity of Southern California · USInstitute of Cancer Research · GBNational Cancer Institute · USOslo University Hospital · NOThe University of Texas MD Anderson Cancer Center · USCancer Research UK · GBDivision of Cancer Epidemiology and GeneticsSeattle Cancer Care Alliance · USStanford University · USUniversity of Washington · USWalter Reed Army Institute of Research · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Robert H. Vonderheide · 1985 to 2026
$222.3M
Clinical Genetic Studies of Familial and Hereditary Cancer SyndromesZIACP010144 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$111.8M
Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI A. Clementina Mesaros · 2006 to 2026
$35.3M
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3U01CA098758 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2003 to 2010
$11.0M
MOLECULAR EPIDEMIOLOGY OF TESTICULAR CARCINOMAR01CA085914 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SCHWARTZ, STEPHEN M · 2000 to 2009
$8.4M
A Genetic Linkage Study of Testicular CancerR01CA102042 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CORTESSIS, VICTORIA K · 2004 to 2009
$3.9M
Inherited genetic variation and predisposition to testicular germ cell tumorR01CA114478 · NCI · UNIVERSITY OF PENNSYLVANIA · PI NATHANSON, KATHERINE L. · 2007 to 2011
$3.1M
Cancer Research UK 10589NCI NIH HHS P30 CA016520NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA085914NCI NIH HHS R01CA085914NCI NIH HHS R01 CA102042NCI NIH HHS R01CA102042NCI NIH HHS R01 CA114478NCI NIH HHS R01CA114478NCI NIH HHS U01 CA098758NCI NIH HHS U01-CA98758NIEHS NIH HHS P30 ES013508PHS HHS HHSN261200655004CWellcome Trust
6 · The paper itself

Abstract

We conducted a meta-analysis to identify new susceptibility loci for testicular germ cell tumor (TGCT). In the discovery phase, we analyzed 931 affected individuals and 1,975 controls from 3 genome-wide association studies (GWAS). We conducted replication in 6 independent sample sets comprising 3,211 affected individuals and 7,591 controls. In the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E. These new TGCT susceptibility loci contain biologically plausible genes encoding proteins important for male germ cell development, chromosomal segregation and the DNA damage response.

Indexed as

AlgorithmsCase-Control StudiesChromosomes, HumanGenetic LociGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansLinkage DisequilibriumMaleModels, GeneticNeoplasms, Germ Cell and EmbryonalPolymorphism, Single NucleotideRisk FactorsTesticular Neoplasms

Identifiers

PMID23666239
PMCPMC3723930
OpenAlexW1964230979

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.